NCT04487327 is a NA clinical trial of Dry Needling in Ankle and or Hindfoot Injury, sponsored by Regis University.

Who is sponsoring NCT04487327?

NCT04487327 is sponsored by Regis University.

What drugs are being tested in NCT04487327?

Interventions in NCT04487327: Dry Needling.

What condition does NCT04487327 study?

NCT04487327 studies Ankle and or Hindfoot Injury.

Is NCT04487327 still recruiting?

NCT04487327 is currently completed. Last updated 10 October 2023.

Last reviewed 2023-10-10 · How we verify

NCT04487327

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

The Effect of Needle Placement on Muscle Stiffness, Gait, Balance, Pain and Functional Outcomes in Individuals With Injury to the Ankle and/or Hindfoot

Completed NA Last updated 10 October 2023

What this trial tests

NA trial testing Dry Needling in Ankle and or Hindfoot Injury in 75 participants. Completed in 1 September 2023.

Timeline

1 October 2020

Primary endpoint
31 August 2023

1 September 2023

Quick facts

Lead sponsor	Regis University
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	factorial
Masking	double
Primary purpose	treatment
Enrollment	75
Start date	1 October 2020
Primary completion	31 August 2023
Estimated completion	1 September 2023
Sites	1 location across United States

Drugs / interventions tested

Dry Needling

Conditions studied

Ankle and or Hindfoot Injury — all drugs for Ankle and or Hindfoot Injury →

Sponsor

Regis University

Who can join

Adults 18 to 60, any sex, with Ankle and or Hindfoot Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this randomized controlled trial is to assess the effect of DN at either the site of the identified myofascial trigger point/s (MTrP) of in the same muscle, but away from the MTrP site/s in individuals with ankle and/or hindfoot injury. Assessments will be of self-reported outcomes, self-reported pain, gait, balance, muscle stiffness, and pain pressure threshold. The secondary purpose of this study is to determine the validity of dry needling specific muscles of the lower extremity based upon needle placement, location relative to anatomical structures and accuracy of needle placement in muscle using ultrasound imaging.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Dry Needling

Trials testing the same drug.

NCT07511751 — COMPARISON OF THREE TREATMENT MODALITIES İN MYOFASCIAL PAIN SYNDROME · NA · recruiting
NCT07456735 — Comparison of the Effectiveness of Dry Needling Versus the Combination of Dry Needling and Local Anesthetic Injection in · Phase 4 · not yet recruiting
NCT07270276 — The Impact of Dry Needling on Electrophysiological and Ultrasound-based Biomarkers for Myofascial Pain · NA · recruiting
NCT07133139 — Treatment Validation for Myofascial Pain · NA · recruiting
NCT07190768 — Effectiveness of Kinesiologic Taping and Dry Needling in the Treatment of Subacromial Pain Syndrome · NA · not yet recruiting

Other Regis University trials

Trials by the same sponsor.

NCT05015088 — Effectiveness of Gastrocnemius Stretching · completed
NCT03689283 — The Effect of Dry Needling on Muscle Stiffness, Gait, Motion, and Strength in Healthy Individuals With Trigger Points · NA · completed
NCT04223245 — A Home Program Using Multimodal Sensory Feedback for People With Parkinson Disease · NA · completed
NCT04040218 — Trigger Point Dry Needling Practice in Colorado: Practitioner and Patient · NA · completed
NCT04164303 — Conservative Management of DeQuervain's Tendinopathy With an Orthopaedic Manual Therapy Approach Emphasizing First CMC M · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04487327 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Regis University
Last refreshed: 10 October 2023

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04487327.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing